Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 posit - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 posit

General Cancer News Latest Breast Cancer News from Moreover Technologies

Prev

Previous Post

Next Post

Next

04-21-2011, 06:20 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Merrimack initiates dosing in MM-111 combination Phase 1 study in advanced HER2 posit Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors. More...

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 04:20 PM.

free webpage hit counter